Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial

Procedural sedation of ASA III/IV patients has increased risk. Remimazolam (an ultra-short-acting benzodiazepine) has proven safe and efficient for outpatient colonoscopy sedation. A double-blind, randomized, multi-center, parallel group trial was performed, comparing remimazolam to placebo with an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Digestive and liver disease 2021-01, Vol.53 (1), p.94-101
Hauptverfasser:	Rex, Douglas K., Bhandari, Raj, Lorch, Daniel G., Meyers, Michael, Schippers, Frank, Bernstein, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Benzodiazepines - administration & dosage Benzodiazepines - adverse effects Colonoscopy Colonoscopy - methods Conscious Sedation - methods Double-Blind Method High risk colonoscopy Humans Hypnotics and Sedatives - administration & dosage Hypnotics and Sedatives - adverse effects Middle Aged Prospective Studies Remimazolam Sedation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!